Delusional Disorder
Delusional disorder, previously called paranoid disorder, is a type of serious mental illness called a psychotic disorder. People who have it can’t tell what’s real from what is imagined. Delusions are the main symptom of delusional disorder. They’re unshakable beliefs in something that isn’t true or based on reality.
Cluster Number:
Wiki Number: W053
Diagnosis: Delusional Disorder
US Patients: 1% of mental health admissions
World Patients:
Sex Ratio: M;W1½
Age Onset: Age 40
Brain Area: neurotransmitters
Symptoms: strong beliefs, despite evidence; psychotic-out of touch with reality; holds them defensively
Progression: Types: erotomanic – another loves me; grandiose, jealous, persecutory, somatic-error on a medical condition or defect.
Causes: genetic; neurotransmitter, familial component
Medications:
Therapies:
Youtube Video: Delusions of Grandeur
Amazon or Library Book:
Tame My Viking Brain
Amazon or Library Book:
The Disordered Mind
Click the book to link or order from Amazon.
Click the book to link or order from Amazon.
Support Group: nami.org; 800-950-6264;
(National Alliance on Mental Illness)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.03.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Transient Psychotic Relapse Following COVID-19 in a Stable Schizophrenia Patient on Paliperidone Palmitate: A Case Reportby Syed Ali Bokhari on December 30, 2024
Schizophrenia is a chronic psychiatric disorder marked by severe disturbances in thought, perception, and behavior. Long-acting injectable (LAI) antipsychotics, such as paliperidone, are widely used to promote sustained remission and ensure medication adherence, especially in patients prone to relapse. However, the COVID-19 pandemic has introduced unique challenges, with studies indicating that infections like COVID-19 may exacerbate psychiatric symptoms through neuroinflammatory pathways. This...
- GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIAby K Kovaleva on December 26, 2024
Schizophrenia is a multifaceted psychiatric disorder characterized by hallucinations, delusions, cognitive impairments, and behavioral disturbances. Genetic factors significantly contribute to its pathogenesis, accounting for approximately 80% of the heritability. Globally, about 1% of the population is affected by schizophrenia, with 45,054 individuals in Kazakhstan receiving medical treatment for the condition, indicating a prevalence rate of 238,6 per 100,000 people. The rise in mental health...
- Towards the DSM-6: The intersection of OCD and psychosis. Expert perspectives on insight in the diagnosis of OCDby Steffen Moritz on December 13, 2024
In 1994, the DSM-IV added the specifier "with poor insight" to the diagnostic criteria of obsessive-compulsive disorder (OCD). The DSM-5 went one step further and now allows clinicians to diagnose OCD "with absent insight/delusional beliefs," thereby blurring the long-standing distinction between OCD and psychosis. The present study surveyed OCD experts as to their opinions on the insight specifier and the future classification of OCD. The final sample comprised 60 OCD experts, with a subgroup...
- Potential research priorities for understanding and treating severe paranoia (persecutory delusions): a priority-setting partnership between patients, carers, mental health staff, and researchersby David Ariel Sher on December 4, 2024
CONCLUSIONS: There was a good deal of consensus in key questions-covering many aspects of understanding, treatment, and support-to be answered about severe paranoia. Most questions were considered largely equally important.